745 results on '"Zecca, Chiara"'
Search Results
102. Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
103. Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
104. Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors
105. Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry
106. Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry
107. The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing
108. Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study
109. Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry
110. Engagement in volunteering activities by persons with multiple sclerosis in Switzerland
111. Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
112. Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
113. Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland--A Structured Commentary, Update 2022.
114. What can we Learn from an Electronic Health Diary Campaign?: An observational nested study in the Swiss Multiple Sclerosis Registry (Preprint)
115. Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES
116. Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry
117. Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors
118. Neuroimaging Findings in a Patient with Anti-IgLON5 Disease: Cerebrospinal Fluid Dynamics Abnormalities
119. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
120. Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 years
121. Additional file 1 of Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires
122. Utilità della citofluorimetria a flusso su liquido da BAL nella diagnosi di Istiocitosi a cellule di Langerhans (ICL)
123. Influence of blood contamination on the salivary cortisol level
124. Clinic and genetic predictors in response to erenumab
125. European Incidence of Syndromes Associated with Frontotemporal Lobar Degeneration
126. Leg movement activity during sleep in multiple sclerosis with and without restless legs syndrome
127. Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis
128. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5- year, multicentre study.
129. Diagnostic and prognostic role of plasma phosphorylated neurofilament heavy chain (pNf-H) in amyotrophic lateral sclerosis
130. proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay
131. Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis
132. The Role of Age on Beta-Amyloid1–42 Plasma Levels in Healthy Subjects
133. Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain Processing
134. Electronic Health Diary Campaigns to Complement Longitudinal Assessments in Persons With Multiple Sclerosis: Nested Observational Study.
135. Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants
136. Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors
137. Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
138. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
139. A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer’s Disease in a Large Italian Family
140. The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
141. Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study
142. Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.”
143. 519 Restless Legs and Periodic Limb Movements in 86 patients with Multiple Sclerosis
144. A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacy
145. sj-docx-1-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
146. sj-pdf-2-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
147. sj-docx-2-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
148. sj-pdf-3-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
149. sj-doc-2-msj-10.1177_13524585211045545 – Supplemental material for Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis
150. sj-doc-1-msj-10.1177_13524585211045545 – Supplemental material for Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.